REPL Message Board Post 9944168 | Replimune Group Inc.
home / stock / repl / repl message board
guttridgel
(investorshub)
Posted on: Mar/21/2022 21:47:11
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168278838
Link to webcast https://wsw.com/webcast/cc/repl2/1432638
News, Short Squeeze, Breakout and More Instantly...
-
- Led by a life-sciences focused institutional investor, with participation from Redmile Group, RTW Investments, Boxer Capital and other institutional investors - - Financing follows strong primary analysis data from the RP1 IGNYTE clinical trial in anti-PD1 failed melanoma; BLA fi...
-
WOBURN, Mass., June 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that Sushil Patel, Chief Executive Officer of Replimune, will present at the Gold...
-
2024-06-07 07:00:05 ET Robert Burns from H.C. Wainwright issued a price target of $17.00 for REPL on 2024-06-07 06:07:00. The adjusted price target was set to $17.00. At the time of the announcement, REPL was trading at $7.11. The overall price target consensus is at $26...